R1 RCM (NASDAQ:RCM) announced its quarterly earnings results on Thursday. The financial services provider reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.01, Briefing.com reports. R1 RCM had a negative net margin of 2.19% and a negative return on equity of 97.14%. The company had revenue of $275.90 million for the quarter, compared to the consensus estimate of $266.37 million. During the same quarter in the prior year, the firm earned ($0.26) earnings per share. The company’s revenue for the quarter was up 87.3% compared to the same quarter last year. R1 RCM updated its FY 2019 guidance to EPS.
Shares of NASDAQ:RCM traded up $0.44 during trading on Friday, reaching $12.28. The stock had a trading volume of 2,534,879 shares, compared to its average volume of 894,862. The company has a debt-to-equity ratio of 56.51, a current ratio of 1.00 and a quick ratio of 1.00. The firm has a market cap of $1.31 billion, a PE ratio of -38.38 and a beta of 0.14. R1 RCM has a fifty-two week low of $7.10 and a fifty-two week high of $12.30.
Several large investors have recently bought and sold shares of RCM. NumerixS Investment Technologies Inc acquired a new position in shares of R1 RCM in the first quarter valued at approximately $58,000. PNC Financial Services Group Inc. raised its position in shares of R1 RCM by 64.5% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,463 shares of the financial services provider’s stock valued at $59,000 after buying an additional 2,926 shares during the last quarter. Quantamental Technologies LLC acquired a new position in shares of R1 RCM in the first quarter valued at approximately $67,000. Bank of Montreal Can raised its position in shares of R1 RCM by 1,501.7% in the fourth quarter. Bank of Montreal Can now owns 11,388 shares of the financial services provider’s stock valued at $90,000 after buying an additional 10,677 shares during the last quarter. Finally, Falcon Point Capital LLC acquired a new position in shares of R1 RCM in the fourth quarter valued at approximately $112,000. 65.69% of the stock is owned by institutional investors and hedge funds.
R1 RCM Company Profile
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.
Featured Story: Return on Equity (ROE)
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.